Srs Capital Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Srs Capital Advisors, Inc.
- $901 Million
- Q1 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 97 shares of CRL stock, worth $19,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97
Previous 97
-0.0%
Holding current value
$19,579
Previous $22,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
730Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.04 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$423 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$379 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$305 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...